Literature DB >> 22508829

Assessing the clinical relevance of oncogenic pathways in neoadjuvant breast cancer.

Paolo Verderio.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22508829     DOI： 10.1200/JCO.2012.41.7386

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  3 in total

1.  Comment on 'Circulating cell-free miRNAs as biomarker for triple-negative breast cancer'-Methodological challenges in combining miRNAs as circulating biomarkers.

Authors:  P Verderio; S Bottelli; M Lecchi; M Plebani; M Gariboldi; S Pizzamiglio; C M Ciniselli
Journal:  Br J Cancer       Date:  2016-04-21       Impact factor: 7.640

2.  Developing miRNA signatures: a multivariate prospective.

Authors:  Paolo Verderio; Stefano Bottelli; Sara Pizzamiglio; Chiara Maura Ciniselli
Journal:  Br J Cancer       Date:  2016-06-28       Impact factor: 7.640

3.  The focus on sample quality: Influence of colon tissue collection on reliability of qPCR data.

Authors:  Vlasta Korenkova; Jana Slyskova; Vendula Novosadova; Sara Pizzamiglio; Lucie Langerova; Jens Bjorkman; Ondrej Vycital; Vaclav Liska; Miroslav Levy; Karel Veskrna; Pavel Vodicka; Ludmila Vodickova; Mikael Kubista; Paolo Verderio
Journal:  Sci Rep       Date:  2016-07-07       Impact factor: 4.379
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.